(Q39307093)

10 September 2017

title

Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders (English)

1 reference

10 September 2017

5

1 reference

10 September 2017

6

Douglas A Drossman

1 reference

10 September 2017

Madhusudan Grover

1

1 reference

10 September 2017

Spencer D Dorn

series ordinal

2

1 reference

10 September 2017

Stephan R Weinland

series ordinal

3

1 reference

10 September 2017

Christine B Dalton

series ordinal

4

1 reference

10 September 2017

language of work or name

1 reference

26 February 2009

1 reference

Digestive Diseases and Sciences

10 September 2017

published in

1 reference

10 September 2017

volume

54

1 reference

10 September 2017

issue

6

1 reference

10 September 2017

page(s)

1284-1291

1 reference

Sexual and physical abuse and gastrointestinal illness. Review and recommendations

10 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-0723-6

Quetiapine fumarate (Seroquel): a new atypical antipsychotic

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-0723-6

Sleep-promoting properties of quetiapine in healthy subjects

21 January 2018

1 reference

12 December 2020

An open-label study of quetiapine in the treatment of fibromyalgia

1 reference

12 December 2020

Treatment of Functional GI Disorders With Psychotropic Medicines: A Review of Evidence With a Practical Approach

1 reference

12 December 2020

Polysomnographic and Actigraphic Evidence of Sleep Fragmentation in Patients with Irritable Bowel Syndrome

1 reference

12 December 2020

Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders

1 reference

12 December 2020

Irritable bowel syndrome, anxiety, and depression: what are the links?

1 reference

12 December 2020

Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder?

1 reference

12 December 2020

The Atypical Neuroleptics Clozapine and Olanzapine Differ Regarding Their Antinociceptive Mechanisms and Potency

1 reference

12 December 2020

Atypical uses of atypical antipsychotics

1 reference

12 December 2020

Sleep disturbances in clinic patients with functional bowel disorders

1 reference

12 December 2020

Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions

1 reference

12 December 2020

Do the second-generation "atypical neuroleptics" have analgesic properties? A structured evidence-based review

1 reference

12 December 2020

Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.

1 reference

12 December 2020

Effects of duloxetine on painful physical symptoms associated with depression

1 reference

12 December 2020

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

1 reference

12 December 2020

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

1 reference

12 December 2020

Irritable bowel syndrome: toward an understanding of severity

1 reference

12 December 2020

A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing

1 reference

12 December 2020

Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study.

1 reference

12 December 2020

Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study.

1 reference

12 December 2020

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

1 reference

12 December 2020

Medication augmentation after the failure of SSRIs for depression.

1 reference

12 December 2020

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy

1 reference

12 December 2020

A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain

1 reference

12 December 2020

Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study

1 reference

12 December 2020

What determines severity among patients with painful functional bowel disorders?

1 reference

12 December 2020

Health status by gastrointestinal diagnosis and abuse history.

1 reference

12 December 2020

10.1007/S10620-009-0723-6

Identifiers

DOI

1 reference

10 September 2017

1 reference